Semaglutide (GLP-1 Receptor Agonist)2mg Injectable Solution Suppliers & Bulk Manufacturers

Available Forms: Injectable solution (prefilled pen)

Available Strengths: 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 2 mg/0.5 mL

Reference Brands: Ozempic(EU & US)

Category: Diabetes

Semaglutide is a GLP-1 receptor agonist that mimics the action of incretin hormones to enhance insulin secretion, suppress glucagon release, and slow gastric emptying, helping control blood sugar. It is used for type 2 diabetes management and chronic weight control in obese or overweight adults, improving glycemic levels and promoting satiety.

Product Description:

Semaglutide, a GLP-1 receptor agonist available as an injectable solution (e.g., Ozempic, Wegovy), is FDA-approved in the USA for type 2 diabetes and chronic weight management in adults. It requires Boxed Warnings for potential thyroid C-cell tumors and must meet GMP, labeling, and post-marketing surveillance standards. In the EU, semaglutide is centrally approved by the EMA for the same indications, with stringent requirements for Risk Management Plans (RMPs) and pharmacovigilance reporting. Ongoing clinical safety and batch quality oversight are essential in both markets. Explore compliant supply options at Pharmatradz.com.

Patent and generic status: generic semaglutide can legally be supplied in some markets but not yet in others. See our guide, Semaglutide patent expiry by country, before placing an order.

Also known as: semaglutida (Spanish, Portuguese), sémaglutide (French), Semaglutid (German), семаглутид (Russian), سيماغلوتايد (Arabic), 司美格鲁肽 (Chinese), セマグルチド (Japanese), 세마글루티드 (Korean), เซมากลูไทด์ (Thai).